PharmiWeb.com - Global Pharma News & Resources
04-Feb-2019

Global Cervical Cancer Treatment Market Report 2019: Analysis & Trends 2015-2017 & Industry Forecasts 2018-2027 - ResearchAndMarkets.com

The "Global Cervical Cancer Treatment Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The Global Cervical Cancer Treatment Market is poised to grow strong during the forecast period 2017 to 2027.

Some of the prominent trends that the market is witnessing include increasing R&D expenditure in oncologic diseases, improvement of systemic chemotherapy and rise in conservative treatment in early stage disease.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Report Highlights:

  • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
  • Market forecasts till 2027, using estimated market values as the base numbers
  • Key market trends across the business segments, Regions and Countries
  • Key developments and strategies observed in the market
  • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
  • In-depth company profiles of key players and upcoming prominent players
  • Growth prospects among the emerging nations through 2027
  • Market opportunities and recommendations for new investments

Key Topics Covered:

1 Market Outline

1.1 Research Methodology

1.1.1 Research Approach & Sources

1.2 Market Trends

1.3 Regulatory Factors

1.4 Product Analysis

1.5 End User Analysis

1.6 Strategic Benchmarking

1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Increasing R & D expenditure in Oncologic Diseases

3.1.2 Improvement of Systemic Chemotherapy

3.1.3 Rise in Conservative Treatment in Early Stage Disease

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

3.4.1 Bargaining power of suppliers

3.4.2 Bargaining power of buyers

3.4.3 Threat of substitutes

3.4.4 Threat of new entrants

3.4.5 Competitive rivalry

4 Cervical Cancer Treatment Market, By Treatment

4.1 Chemotherapy

4.1.1 Carboplatin

4.1.2 Bevacizumab

4.1.3 Paclitaxel

4.1.4 Oxorubicin

4.1.5 Cisplatin

4.1.6 Other Chemotherapies

4.2 Hormone Therapy

4.2.1 Progesterone

4.2.2 Oestrogen

4.2.3 Testosterone

4.2.4 Progestogens

4.3 Radiation Therapy

4.3.1 Brachytherapy

4.3.2 External Beam Radiation

4.4 Surgery

4.4.1 Laser Surgery

4.4.2 Trachelectomy

4.4.3 Radical Hysterectomy

4.4.4 Cryosurgery

4.4.5 Simple Hysterectomy

4.4.6 Other Surgeries

4.5 Targeted Therapy

4.5.1 Pazopanib

4.5.2 Bevacizumab

4.6 Loop Electrosurgical Excision Procedure (LEEP)

4.7 Cone Biopsy

4.8 Cold Knife Conization

5 Cervical Cancer Treatment Market, By Type

5.1 Adenosquamous Carcinomas

5.2 Squamous Cell Carcinomas

5.3 Adenocarcinomas

6 Cervical Cancer Treatment Market, By Material

6.1 Biologically Derived Materials

6.2 Synthetic Materials

6.3 Genetically Engineered Materials

6.4 Other Materials

7 Cervical Cancer Treatment Market, By Product

7.1 Treatment

7.1.1 Keytruda

7.1.2 Generics

7.1.3 Avastin

7.1.4 Other Treatments

7.2 Prevention

7.2.1 Cervarix

7.2.2 Gardasil/Gardasil 9

8 Cervical Cancer Treatment Market, By Disease Indication

8.1 Early Invasive Stage

8.2 Advanced Invasive Stage

8.3 Pre-malignant lesions

9 Cervical Cancer Treatment Market, By Distribution Channel

9.1 Online Pharmacies

9.2 Hospital Pharmacies

9.3 Retail Pharmacies

10 Cervical Cancer Treatment Market, By End User

10.1 Diagnostic Centers

10.2 Pharmacies

10.3 Cancer Palliative care clinics

10.4 Hospitals

11 Cervical Cancer Treatment Market, By Geography

11.1 North America

11.1.1 US

11.1.2 Canada

11.1.3 Mexico

11.2 Europe

11.2.1 Germany

11.2.2 U.K

11.2.3 Italy

11.2.4 France

11.2.5 Spain

11.2.6 Rest of Europe

11.3 Asia Pacific

11.3.1 China

11.3.2 Japan

11.3.3 India

11.3.4 Australia

11.3.5 New Zealand

11.3.6 Rest of Asia Pacific

11.4 Middle East

11.4.1 Saudi Arabia

11.4.2 UAE

11.4.3 Rest of Middle East

11.5 Latin America

11.5.1 Argentina

11.5.2 Brazil

11.5.3 Rest of Latin America

11.6 Rest of the World (RoW)

11.6.1 South Africa

11.6.2 Others

12 Key Player Activities

12.1 Acquisitions & Mergers

12.2 Agreements, Partnerships, Collaborations and Joint Ventures

12.3 Product Launch & Expansions

12.4 Other Activities

13 Leading Companies

13.1 Pfizer Inc

13.2 Bristol-Myers Squibb Company

13.3 Novartis

13.4 Eli Lilly And Company

13.5 Allergan, Plc.

13.6 GlaxoSmithKline

13.7 Hoffmann La Roche Ltd

13.8 Biocon Ltd.

13.9 Genentech USA

13.10 Merck & Co., Inc.,

13.11 Teva Pharmaceutical Industries Ltd.

13.12 Varian Medical Systems, Inc.

13.13 Ethicon, Inc.

13.14 Hetero Drugs Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/xttbq4/global_cervical?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190204005288/en/

Editor Details

Last Updated: 04-Feb-2019